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ing by ElsAbstract Purpose: To evaluate the correlation of the apparent diffusion coefﬁcient (ADC) using
diffusion weighted imaging (DWI) and early/delayed enhancement (E/D) ratio using dynamic con-
trast enhanced magnetic resonance imaging (DCE-MRI) with histological grading in malignant
breast lesions.
Material and methods: Thirty-one women with 34 histopathologically proved malignant breast
lesions underwent MRI within 2 weeks prior to surgery. MRI examination included T1 and
T2 W sequences, DWI and DCE-MRI. ADC values and E/D ratios are correlated with the histo-
logical grades.
Results: The mean ADC of the malignant lesions was 0.85 ± 0.12 · 103 mm2/s. The mean ADC
values of grade I, II and III were 0.96 ± 0.12 · 103 mm2/s, 0.87 ± 0.07 · 103 mm2/s and
0.75 ± 0.12 · 103 mm2/s, respectively. Tumours with higher grade showed signiﬁcantly lower
ADC value (p= 0.0001) compared with lower grade and there is an inverse correlation between
ADC value and histological grade (r= 0.62, p-value = 0.0001). The mean E/D ratio for grade4038955.
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452 G.K. Gouhar et al.I, II and III tumours were 0.98 ± 0.04, 1.01 ± 0.05 and 1.07 ± 0.08, respectively. Tumours with
higher grade showed signiﬁcantly higher E/D ratio (p= 0.005) compared with lower grade and
there was a direct correlation between E/D ratio and histological grade (r= 0.44, p= 0.008).
Conclusion: DWI is a useful diagnostic parameter with signiﬁcantly higher correlation with the his-
tological grade of breast cancer than DCE MRI, which is an important factor for proper treatment
selection.
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Detection of breast lesions has become more sensitive in mam-
mography, ultrasound and MRI. However, the characteriza-
tion of the detected lesions can be difﬁcult (1–5). Diffusion
weighted imaging has become an important technique for
detecting breast tumours and distinguishing between malignant
and benign breast lesions (6,7). DW MRI is based on the prin-
ciple that random motion of molecules during the interval of
excitation and signal measurement reduces the amplitude of
the resulting signal. The application of appropriate pulse se-
quences allows the measurement of the signal cancellation
due to diffusion in a given direction. While normal tissue exhib-
its gross signal loss, areas with restricted motion of molecules
show less signal loss and become bright in diffusion weighted
images. The value of diffusion of water in tissue is called the
apparent diffusion coefﬁcient (ADC) (6). DWI is sensitive to
biophysical characteristics of tissue such as cell density, mem-
brane integrity and microstructure (8,9). High cell proliferation
in malignant tumours increases cellular density, creating more
barriers to the extracellular diffusion, resulting in signal loss
and reducing the ADC to be lower than that seen in benign
breast lesions or normal tissues (10–17). So DWI is a useful tool
for tumour detection and characterization as well as for moni-
toring and predicting treatment response (18).
Dynamic contrast enhanced magnetic resonance (MR)
imaging has emerged as a promising modality for the detec-
tion, diagnosis and staging of breast cancer. MR imaging pro-
vides important information not only on the morphology of
the lesions but also on the functional aspect reﬂected by the
temporal and spatial uptake of the contrast medium. Integra-
tion of both kinetic and morphological features is important
for accurate diagnosis (19–21).
Dynamic contrast enhanced imaging detects changes in the
vascularity, vascular permeability, interstitial pressure and
extracellular space. However it provides no direct information
about tumour cellularity, which is known to be an important
index of tumour grade. Diffusion weighted MRI provides un-
ique information about the cellularity and the state of molec-
ular motion of water (15). It also has the advantages of
being of short examination time and no need to inject contrast
medium (22,23).
The aim of this study was to investigate the relationship be-
tween histopathological grade of breast cancer and both DWI
represented by ADC and the enhancement ratio (E/D ratio) on
dynamic contrast enhanced MRI as the histopathological
grade is one of the important factors used in selection and
planning of breast cancer. Histopathological grading of the
lesions is done using Nottingham grading system. The mean
and the standard deviation of the ADC and E/D ratio for all
lesions and for each histological grade were calculated.2. Materials and methods
2.1. Patients
This prospective study comprised 49 women with suspicious
breast lesions based on physical examination, mammography
and ultrasonography. Inclusion criteria were: histopathologi-
cally proved cancer patients after excisional biopsy or surgical
excision. Exclusion criteria were: patients who had neoadju-
vant chemotherapy or biopsy before MR examination, or
had contraindication to MR imaging (e.g., pacemaker, metal-
lic implant, severe claustrophobia). Institutional review board
approval and informed consent was taken from all patients.
Eighteen patients were excluded from the study due to previ-
ous therapy (n= 5), biopsy prior to MRI examination
(n= 9), and improper MRI study (n= 4). So a total of 31
patients (Age range 38–74 years; mean 47.4 years,) with 34
lesions were included in this study.
3. MR imaging protocol
Breast MR imaging was performed with the use of a 1.5-T MR
(Achieva, Philips Medical Systems, Netherland B.V.) by using
a standard bilateral breast coil. The patients were placed in a
prone position in the breast coil and initial scout views in axial,
coronal, and sagittal planes of both breasts were taken. These
scout images were used for the subsequent series to cover the
whole parenchyma. MRI protocol consisted of precontrast ser-
ies including T1and T2WI, dynamic contrast enhanced MRI
and diffusion weighted imaging. T1W sequence in axial view
was taken with the following parameters (TR/TE: 415/10),
NEX: 1, slice thickness/interslice gap: 3.0 mm/0.0, ﬂip angle:
90, FOV: 360. T2W sequences in axial and sagittal or coronal
views were taken with the following parameters (TR/TE: 4900/
120), NEX: 1, slice thickness/interslice gap: 3.0 mm/0.0, ﬂip
angle: 90, FOV: 360 mm.
3.1. Diffusion weighted MR imaging
Axial DWI with single shot echo planar imaging (EPI) was
performed at b values 0 and 1000 with the following parame-
ters: TR/TE: 2700/72 ms, 3 mm slice thickness, 1 mm intersec-
tion gap, FOV 300 mm. Apparent diffusion coefﬁcient (ADC)
maps were automatically calculated by MRI machine software
and included in the sequence.
3.2. Dynamic contrast enhanced (DCE) MRI
This was obtained using a T1-weighted sequence with fat sup-
pression (dynamic THRIVE protocol) with the following
parameters: TR 7 ms, TE 3 ms, ﬂip angle 12, ﬁeld of view
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consisted of 6 individual dynamic series each lasting for
1:05–1:07 min; one was obtained before and ﬁve after the rapid
bolus intravenous injection of gadopentetate dimeglumine at a
dose of 0.1 mmol per kilogram of body weight, followed by a
20 mL saline solution ﬂush. After the dynamic series, image
subtraction was done to suppress the signal from fat, and
enhancing lesions were clearly identiﬁed on the subtracted
images.
4. Image interpretation and data analysis
4.1. Interpretation of MR images
MR images including DCE-MRI and DWI were evaluated
independently by the two radiologists sharing in the study.
4.2. Diffusion weighted MR imaging
The visualized lesion in the dynamic scan has to be identiﬁed in
the corresponding slice of the diffusion weighted images b 0
and 1000 then a region of interest (ROI) is drawn on the lesion
(cystic and necrotic areas were avoided) and copied to the
ADC map. The scanner software provides the mean value
within the ROI which equals the ADC value (multiplied by
103 mm2/s).
4.3. DCE-MRI analysis
Time–signal intensity plots of dynamic images were generated
using computer assisted diagnosis (CAD) software as percent-
age enhancement (y-axis) versus time (x-axis) of a region of
interest (ROI) placed in the detected lesion. ROI was selec-
tively placed on the areas of the most rapid and strongest
enhancement.
The enhancement kinetics were divided into two phases: the
early enhancement phase (E), deﬁned as enhancement patterns
before the curve starts to change (within the ﬁrst 2 and 1/
2 min), and the delayed phase (D), deﬁned as enhancement
pattern around 6 min after the curve starts to change. The
enhancement ratio in the early to the delayed phase was calcu-
lated by dividing E/D for each lesion.
5. Histopathological analysis
Histopathological grading was analysed by a pathologist with
experience in the breast pathology. The examined samples
were stained with haematoxylin-eosin for evaluation of mor-
phologic features, then histological grades were assessed using
the Nottingham grading system (Elston–Ellis modiﬁcation of
the Scarff–Bloom–Richardson (SBR) grading system) (24)
(Table 1), in which a score of I–III was assigned for tubule for-
mation, pleomorphism and mitotic count. The total scoreTable 1 Elston–Ellis modiﬁcation of the Scarff–Bloom–Richardson
Tubular formation Mitotic count
1. Majority of tumour (>75%) 0–9 mitosis/HPF
2. Moderate degree (10–75%) 10–19 mitosis/HP
3. Little or none (<10%) 20 or more mitocould range from 3 to 9, with a total of 3–5 representing grade
I, a total of 6 or 7 representing grade II, and a total of 8 or 9
representing grade III.6. Statistical analysis
Statistical analysis was performed by using statistical software
SPSS version 10. Our patients were divided into three groups
according to the histological grading; Grade I, II and III.
The mean and the standard deviation of the ADC and E/D ra-
tio for all lesions and for each histological grade were calcu-
lated. One way analysis of variants (ANOVA) and post-Hoc
(lsd) analysis were used to test the difference in ADC and E/
D ratio means between the different histological grades. The
Spearman Rank correlation was used to correlate the ADC va-
lue and E/D ratio with the histological grade. The correlation
coefﬁcient (r) and the p-value were calculated. The p 6 0.05 va-
lue was considered statistically signiﬁcant.7. Results
Thirty one female patients are included in this study (age range
38–74 years; mean 47.4 years,) with a total of 34 lesions. Histo-
pathological analysis revealed 25 invasive ductal carcinomas, 5
ductal carcinomas in situ, 3 invasive lobular carcinomas and 1
invasive tubular carcinoma. The size of the breast cancer var-
ied from 0.9 to 9 cm (mean 3.6 ± 1.8). Seven lesions (20.6%)
were grade I, 17 lesions (50%) grade II and 10 lesions
(29.4%) grade III.
The mean ADC value (Fig. 1) of the malignant lesions was
0.85 ± 0.12 · 103 mm2/s (range 0.51–1.11 · 103 mm2/s).
The mean ADC value of grade I was 0.96 ± 0.12 ·
103 mm2/s, of grade II was 0.87 ± 0.07 · 103 mm2/s and
of grade III was 0.75 ± 0.12 · 103 mm2/s (Table 2). Tumours
with higher grade showed signiﬁcantly lower ADC value
(p= 0.0001) compared with lower grade. There was signiﬁcant
difference in the mean ADC value of tumours of grade I and
III (p= 0.0001) and grade II and III (p= 0.003), however,
there was no signiﬁcant difference between grade I and II
(p= 0.054) (Table 3).
The mean E/D ratio (Fig. 1) for the malignant lesions was
1.02 ± 0.06. The mean E/D ratio for grade I, II and III tu-
mours were 0.98 ± 0.04, 1.01 ± 0.05 and 1.07 ± 0.08, respec-
tively (Table 2). Tumours with higher grade showed
signiﬁcantly higher E/D ratio (p= 0.005) compared with low-
er grade. There was signiﬁcant difference in E/D ratio of tu-
mours of grade I and III (p= 0.003) and grade II and III
(p= 0.006) but there was no signiﬁcant difference between tu-
mours grade I and II (p= 0.385) (Table 3). Illustrative cases
are shown in (Figs. 2–5).
Using Spearman rank correlation test, there were a better
correlation between the histological grade and ADC(SBR) grading system (24).
Nuclear pleomorphism
Small regular uniform cells
F Moderate nuclear size and variation
sis/HPF Marked nuclear variation
Figure 1 The ﬁrst box plots show the mean E/D ratios of the
different histological grades. The mean E/D ratio for grade I was
0.98 ± 0.04, grade II 1.01 ± 0.05 and grade III 1.07 ± 0.08. The
second box plots show the mean ADC values of the different
histological grades. The mean ADC value of grade I was 0.96 ±
0.12 · 103 mm2/s, of grade II was 0.87 ± 0.07 · 103 mm2/s and
of grade III was 0.75 ± 0.12 · 103 mm2/s.
Table 3 One way ANOVA post hoc analysis testing the
difference in the mean ADC and the mean E/D between the
different histological grades.
Grades I
and II
Grades I
and III
Grades II
and III
Mean ADC p= 0.054 p= 0.0001 p= 0.003
Mean E/D ratio p= 0.385 p= 0.003 p= 0.006
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ical grade and E/D ratio (r= 0.44, p= 0.008).
8. Discussion
Breast cancer has a variable biological behaviour and the mor-
phological and cytological pattern of the tumour correlates
with the degree of malignancy. The proper identiﬁcation of
the type of breast cancer can improve the selection of proper
treatment and deﬁnes the patient’s outcome. The histological
type and the tumour stage are indices for the degree of malig-
nancy of the breast cancer (24–26).Table 2 The mean ADC and mean E/D ratio in the different histo
All lesions
Mean ADC (mean ± SD) · 103 mm2/s 0.85 ± 0.12
Mean E/D ratio (mean ± SD) 1.02 ± 0.06Magnetic resonance imaging became an important modal-
ity in characterizing the type and evaluating the extent of the
breast lesions. Dynamic contrast enhanced magnetic resonance
imaging (DCE-MRI) has been a useful technique for the detec-
tion, diagnosis and staging of breast cancer (27–29) and gives
information about the morphology and kinetics of the lesions
and can identify additional lesions and determine the extent of
the tumour before surgery (30).
DWI can provide information about the tumour biology
and physiology and differentiate benign from malignant tu-
mours with progressive decrease in ADC value from benign le-
sions to non invasive and invasive carcinoma and there is a
relationship between ADC and tumour cellularity (31–34).
In this study, the mean ADC of the malignant cases was
0.85 ± 0.12 · 103 mm2/s with the highest value being
1.15 · 103 mm2/s. This is similar to the mean ADC values
reported by other previous studies; 0.89 ± 0.18 · 103 mm2/s
reported by Park et al. (35), 0.97 ± 0.20 · 103 mm2/s by
Guo et al. (6), 1.02 ± 0.23 · 103 mm2/s by Kuroki et al.
(33), 1.03 ± 0.27 · 103 mm2/s by Costantini et al. (36),
1.04 ± 0.15 · 103 mm2/s by Abdel Razek et al. (37) and
1.09 ± 0.27 · 103 mm2/s by Kim et al. (38).
In agreement with the previous studies (6,12,17,31,
32,34,39) where the cut off value of ADC for diagnosing breast
cancer ranged from 1.13 · 103 mm2/s to 1.6 · 103 mm2/s, all
our ADC values did not exceed the cut off value that differen-
tiates benign and malignant breast lesions in these studies.
The mean ADC values of grade I, II and III were
0.96 ± 0.12 · 103 mm2/s, 0.87 ± 0.07 · 103 mm2/s and
0.75 ± 0.12 · 103 mm2/s, respectively. Tumours with higher
grade showed signiﬁcantly lower ADC value (p= 0.0001)
compared with lower grade. There was signiﬁcant difference
in the ADC value of tumours of grade I and III
(p= 0.0001) and grade II and III (p= 0.003) but there was
no signiﬁcant difference between grade I and II (p= 0.054).
This is consistent with Abdel Razek et al. (37) who reported
that there was a signiﬁcant difference between grade I and
III and grade II and III and insigniﬁcant difference between
grade I and II. There was an inverse correlation between
ADC value and histological grade (r= 0.62, p -value =
0.0001) in this study, and this agreed with the previous studies
(6,12,36,37) where a signiﬁcant inverse correlation between
ADC value and tumour grading was detected. Kim et al.
(38) found that the mean ADC in grade III is lower than thatlogical grades.
Grade I Grade II Grade III
0.96 ± 0.12 0.87 ± 0.07 0.75 ± 0.12
0.98 ± 0.04 1.01 ± 0.05 1.07 ± 0.08
Figure 2 Forty-seven year old female patient with right breast cancer. Axial early (a) and late (b) dynamic images show the enhanced
lesion at the right breast with E/D ratio 0.99. Time signal intensity curve of the lesion (c) shows type II platue curve. The lesion is
hyperintense in DWI b= 1000 (d) and is of low signal intensity at ADC map (e) with ADC value equals 0.083 · 103 mm2/s.
Histopathologically the tumour proved to be grade II.
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Figure 3 Forty-four year old female patient with small right breast cancer. Axial early (a) and late (b) dynamic images show a small well
deﬁned laterally located homogenously enhanced lesion at the right breast with E/D ratio 1.01. The lesion is hyperintense at DWI
b= 1000 (c) and is of low signal intensity at ADC map (d). ADC value of the lesion equals 0.092 · 103 mm2/s. Histopathologically the
tumour proved to be grade I.
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reach a statistical signiﬁcance (p= 0.82), however, Yoshikawa
et al. (40) found that the mean ADC of breast cancer did not
signiﬁcantly correlate with cancer cellularity.
Concerning DCE MRI we found that the mean E/D ratio
for grade I, II and III tumours were 0.98 ± 0.04,
1.01 ± 0.05 and 1.07 ± 0.08, respectively. Tumours with high-
er grade showed signiﬁcantly higher E/D ratio (p= 0.005)
compared with lower grade. There was signiﬁcant difference
in E/D ratio of tumours of grade I and III (p= 0.003) andgrade II and III (p= 0.006), however, there was no signiﬁcant
difference between tumours grade I and II (p= 0.385). A di-
rect correlation between E/D ratio and histological grade
(r= 0.44, p= 0.008) was present.
Our results are in agreement with previous studies (9,19,41–
46). Matsubayashi et al. (41) stated that the enhancement ra-
tios of breast carcinoma on dynamic MR images closely corre-
lated with cellular density and the histological and
morphological features. Mussurakis et al. (42) observed a
strong signiﬁcant association between all automated ROI
Figure 4 Forty-two year old female patient with left breast cancer. Axial early (a) and late (b) dynamic images show a large
heterogeneously enhanced lesion at the left breast with E/D ratio 1.03. Time signal intensity curve (c) shows type III wash out curve. The
lesion is hyperintense at DWI b = 1000 (d) with ADC value of 0.081 · 103 mm2/s. Histopathologically the tumour proved to be grade
III.
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studies (19,43–45) reported a signiﬁcant correlation between
the enhancement pattern and histological grade or high cellu-
lar proliferation.
Radjenovic et al. (46) and Lee et al. (19) studied the rela-
tionship between the histological grades of breast tumours
and the pharmacokinetic parameters that reﬂect the capillary
permeability as K trans (transfer constant representing extrav-
asation of Gd-DTPA from the central plasma compartment)
and K ep (the back ﬂux of Gd-DTPA from the extravascularextracellular compartment into the plasma compartment)
and found a statistically signiﬁcant variation of K trans and
K ep with tumour grade (Spearman’s correlation = 0.473, p
< 0.0005), it was higher in grade III tumours than grade I
and II tumours but, there was no signiﬁcant difference between
grade I and II.
Our study has some limitations; ﬁrst, it was difﬁcult to ex-
actly match a histologic specimen with the ROIs selected on
DWI and DCE MRI, second is small areas of necrosis not de-
tected by DCE MR images may increase the ADC value.
Figure 5 Forty-ﬁve year old female patient with left breast cancer. Axial early (a) and late (b) dynamic images show a small well deﬁned
medially located homogenously enhanced lesion at the left breast with E/D ratio 1.02. The lesion is hyperintense at DWI b = 1000 (c) and
is of low signal intensity at ADC map (d) with ADC value of 0.85 · 103 mm2/s. Histopathologically the tumour proved to be grade II.
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fect the signiﬁcance of the results.9. Conclusion
DWI represented by ADC has higher correlation with the
histological grade of the breast cancer than DCE MRI
represented by E/D ratio which is an important factor in
the treatment selection and improvement of the patient
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